v3.26.1
Note 12 - License and Development Agreements (Details Textual) - USD ($)
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Sep. 01, 2024
May 01, 2024
Mar. 01, 2024
Jan. 26, 2024
May 26, 2023
Accounts Payable, Current $ 4,282,000 $ 4,182,000          
Accrued Liabilities, Current 2,667,000 5,232,000          
Convertible Notes Payable, Current 1,400,000 1,350,000          
Convertible Promissory Note Due to Novartis [Member]              
Accounts Payable, Current 3,600,000            
Accrued Liabilities, Current 500,000            
Convertible Notes Payable, Current 1,400,000            
Eisai Royalties Four [Member]              
Royalty, Annual Sales 500,000,000            
License Agreement with Novartis for Dovitinib [Member]              
Accounts Payable and Accrued Liabilities           $ 5,500,000  
Accounts Payable and Accrued Liabilities, Interest Rate, Stated Percentage           5.00%  
Development costs and Out-License Agreement with Smerud [Member]              
Contract with Customer, Liability   200,000          
Contract with Customer, Liability, Revenue Recognized 300,000 $ 0          
Eisai [Member]              
Milestone Payment, Sales 50,000,000            
Licensed Product Sales $ 1,000,000,000            
Maximum [Member] | Eisai Royalties One [Member]              
Royalty Annual Percentage 10.00%            
Royalty, Annual Sales $ 100,000,000            
Maximum [Member] | Eisai Royalty Two [Member]              
Royalty Annual Percentage 10.00%            
Royalty, Annual Sales $ 250,000,000            
Maximum [Member] | Eisai Royalties Three [Member]              
Royalty Annual Percentage 11.00%            
Royalty, Annual Sales $ 500,000,000            
Maximum [Member] | Eisai Royalties Four [Member]              
Royalty Annual Percentage 15.00%            
Maximum [Member] | Eisai [Member]              
Milestone Payment $ 94,000,000            
Minimum [Member] | Eisai Royalties One [Member]              
Royalty Annual Percentage 5.00%            
Royalty, Annual Sales $ 0            
Minimum [Member] | Eisai Royalty Two [Member]              
Royalty Annual Percentage 6.00%            
Royalty, Annual Sales $ 100,000,000            
Minimum [Member] | Eisai Royalties Three [Member]              
Royalty Annual Percentage 7.00%            
Royalty, Annual Sales $ 250,000,000            
Minimum [Member] | Eisai Royalties Four [Member]              
Royalty Annual Percentage 11.00%            
Already Paid [Member]              
License Agreement, Periodic Payment             $ 100,000
Paid Within 10 Days of Fourth Amendment Execution [Member]              
License Agreement, Periodic Payment             50,000
Completion of Capital Raise [Member]              
License Agreement, Periodic Payment             $ 100,000
Payment on or Before March 1, 2024 [Member]              
License Agreement, Periodic Payment         $ 850,000    
Fifth Amendment Agreement [Member]              
License Agreement, Periodic Payment       $ 200,000      
Payment Due by September 1, 2024 [Member]              
License Agreement, Periodic Payment     $ 850,000